Han Xiong Li
Fortuna: 1 034 M $ al 30/09/2026
Fortuna: 1 034 M $ al 30/09/2026
Han Xiong Li is the founder of Apichope Pharmaceutical Group Co., Ltd., founded in 2002, holding the titles of Chairman & General Manager.
Dr. Li currently holds the position of Chairman at Guangdong Zerui Pharmaceutical Co. Ltd. Dr. Li obtained a doctorate from the University of Geneva and an MBA from China Europe International Business School in 2011.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/09/2025 | 189.810.000 ( 44,89 % ) | 942 M $ | 30/09/2026 | |
| 30/09/2025 | 18.630.000 ( 51,07 % ) | 92 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| APICHOPE PHARMACEUTICAL GROUP CO., LTD. | Director Ejecutivo | 11/11/2015 |
Guangdong Zerui Pharmaceutical Co. Ltd.
Guangdong Zerui Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Geneva
University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Europe International Business School
China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ApicHope Pharmaceutical Co., Ltd.
ApicHope Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
Guangdong Zerui Pharmaceutical Co. Ltd.
Guangdong Zerui Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.